Eastman Kodak Co said it plansto sell its 2.3 pct holding in ICN Pharmaceuticals &lt;ICN> andpart of its nine pct holdings in Viratek &lt;VIRA>.    It said the purpose of the investments had been to lay thegroundwork for the creation of its Nucleic Acid ResearchInstitute.    Since that has been achieved, there is no longer any reasonto maintain the equity positions, Kodak said.    Kodak holds 470,000 sahres of ICN, currently trading atabout 18-3/4 and 700,000 of Viratek, trading at 44. Reuter&#3;